Linda Dirven

Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire

Marieke van Leeuwen, Olga Husson, Paola Alberti et al. · Health and Quality of Life Outcomes · 2018 · 236 citations · Full text

Pharmacy, Oncology, Cancer Survivorship Care +16

Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

C. Mircea S. Tesileanu, Linda Dirven, Maarten M.J. Wijnenga et al. · Neuro-Oncology · 2019 · 215 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma

Linda Dirven, Andrew A. Kanner, Gitit Lavy-Shahaf et al. · JAMA Oncology · 2018 · 192 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types

Jammbe Musoro, Corneel Coens, Mirjam A. G. Sprangers et al. · European Journal of Cancer · 2023 · 174 citations · Full text

Medicine, Biostatistics, Oncology +5

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

Maries van den Broek, Naomi B. Klarenbeek, Linda Dirven et al. · Annals of the Rheumatic Diseases · 2011 · 131 citations

Medicine, Immunology, Pharmacotherapy +15